Sensus/$SRTS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sensus
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Ticker
$SRTS
Sector
Primary listing
Employees
54
Headquarters
Website
Sensus Metrics
BasicAdvanced
$51M
-
-$0.05
1.35
-
Price and volume
Market cap
$51M
Beta
1.35
52-week high
$5.92
52-week low
$3.03
Average daily volume
190K
Financial strength
Current ratio
8.143
Quick ratio
5.424
Long term debt to equity
0.659
Total debt to equity
1.143
Profitability
EBITDA (TTM)
-1.045
Gross margin (TTM)
52.18%
Net profit margin (TTM)
-2.26%
Operating margin (TTM)
-3.64%
Effective tax rate (TTM)
-72.36%
Revenue per employee (TTM)
$700,000
Management effectiveness
Return on assets (TTM)
-1.46%
Return on equity (TTM)
-1.62%
Valuation
Price to revenue (TTM)
1.361
Price to book
0.99
Price to tangible book (TTM)
0.99
Price to free cash flow (TTM)
14.637
Free cash flow yield (TTM)
6.83%
Free cash flow per share (TTM)
0.214
Growth
Revenue change (TTM)
3.29%
Earnings per share change (TTM)
-112.73%
3-year revenue growth (CAGR)
-2.85%
3-year earnings per share growth (CAGR)
-67.43%
Sensus News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sensus stock?
Sensus (SRTS) has a market cap of $51M as of August 26, 2025.
What is the P/E ratio for Sensus stock?
The price to earnings (P/E) ratio for Sensus (SRTS) stock is 0 as of August 26, 2025.
Does Sensus stock pay dividends?
No, Sensus (SRTS) stock does not pay dividends to its shareholders as of August 26, 2025.
When is the next Sensus dividend payment date?
Sensus (SRTS) stock does not pay dividends to its shareholders.
What is the beta indicator for Sensus?
Sensus (SRTS) has a beta rating of 1.35. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.